Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
POSTED
21 hours ago
Living With Metastatic Bladder Cancer: Joey's Journey
Watch Joey's story about living with Metastatic Bladder Cancer and his determination to beat it.
POSTED
05-12-22
Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies
The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies.
POSTED
05-09-22
Closing the Representation Gap in Schools, One Black Male Teacher at a Time
The deficit of Black male teachers in the United States is profound. According to the U.S. Department of Education, Black men comprise just 2% of all teachers. The Man the Bay fellowship offers a multi-pronged solution.
POSTED
05-04-22
Opinion: The Road to Ending Visceral Leishmaniasis
If left untreated, VL kills 95% of its victims. Though progress has been made, we still have a way to go and, as we look to the next decade, eliminating VL will continue to be a priority for Gilead Sciences.
POSTED
05-02-22
On Earth Day, Gilead Marks Strides in Environmental Sustainability
This Earth Day, we’re highlighting our longstanding commitment to environmental stewardship. We’ll continue to accelerate our efforts to reduce greenhouse gas emissions, minimize waste generation and operate responsibly.
POSTED
04-27-22
Gilead Sciences Announces Support for the Robert A. Winn Diversity in Clinical Trials Award Program
Read more about the program and its goal of helping enhance the development of therapeutics for all populations.
POSTED
04-21-22
Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
Julie and her husband Bob were enjoying being empty nesters and getting ready to head on a beach vacation when Julie started feeling sick. A few weeks before the trip, Julie’s symptoms – a dry cough and shortness of breath – got worse, so she went to an urgent care center near their home in Lower Bu...
POSTED
04-19-22
The Translatinx Network Helps a Resilient Community 'Live Its Truth'
“In 2005, I began dreaming about starting a trans-led, immigrant-led organization,” she says. “My dream came true two years later when I started the nonprofit.”
POSTED
04-18-22
Tour for Diversity in Medicine, Gilead Sciences and the Advisory Group to SHC Vaccine Equity Program to Receive Booker T. Washington Award From National Minority Quality Forum
The National Minority Quality Forum (NMQF) announced today that it will honor the Tour for Diversity in Medicine, Gilead Sciences and the Advisory Group to SHC Vaccine Equity Program with its highly acclaimed Booker T. Washington Award.
POSTED
04-14-22
Four Questions With Anu Osinusi: Gilead's Commitment to People Living With Viral Hepatitis
Anu Osinusi recently spoke with us about how hepatitis research and treatment have changed over her career, why HDV is considered the “forgotten virus” and what’s next for Gilead.